We are live on ! Find out more
HWAM

Hennion & Walsh Asset Management Portfolio holdings

AUM $3.5B
1-Year Est. Return 41.95%
This Fund
S&P 500
This Quarter Est. Return
+4.77%
1 Year Est. Return
+41.95%
3 Year Est. Return
+93.92%
5 Year Est. Return
+100.55%
10 Year Est. Return
–
AUM
$2.9B
AUM Growth
+$137M
Cap. Flow
+$88.8M
Cap. Flow %
3.06%
Top 10 Hldgs %
17.97%
Holding
1,008
New
71
Increased
442
Reduced
400
Closed
82

Top Buys

Rank Stock Value
1
VGM icon
Invesco Trust Investment Grade Municipals
VGM
+$4.8M
2
NMZ icon
Nuveen Municipal High Income Opportunity Fund
NMZ
+$4.39M
3
MQY icon
BlackRock MuniYield Quality Fund
MQY
+$4.26M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$3.84M
5
OLMA icon
Olema Pharmaceuticals
OLMA
+$3.61M

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$19.8M
2
ETNB
89bio
ETNB
+$3.65M
3
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$3.59M
4
RKLB icon
Rocket Lab Corp
RKLB
+$3.39M
5
VMO icon
Invesco Municipal Opportunity Trust
VMO
+$3.16M

Sector Composition

Rank Sector Weight
1 Technology 12.53%
2 Healthcare 11.66%
3 Financials 9.01%
4 Industrials 7.22%
5 Consumer Discretionary 3.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARDC
226
Are Dynamic Credit Allocation Fund
ARDC
$298M
$3.39M 0.12%
255,119
-9,668
-4% -$131K
TFC icon
227
Truist Financial
TFC
$63.9B
$3.39M 0.12%
68,816
+13,237
+24% +$610K
CW icon
228
Curtiss-Wright
CW
$26.1B
$3.37M 0.12%
6,117
-640
-9% -$357K
MUE
229
DELISTED
BlackRock MuniHoldings Quality Fund II
MUE
$3.37M 0.12%
336,152
-19,459
-5% -$195K
PROK icon
230
ProKidney
PROK
$330M
$3.37M 0.12%
1,503,886
+583,983
+63% +$1.54M
SNPS icon
231
Synopsys
SNPS
$78.7B
$3.34M 0.12%
7,119
+530
+8% +$235K
NCA icon
232
Nuveen California Municipal Value Fund
NCA
$304M
$3.31M 0.11%
370,139
+71,944
+24% +$645K
BSCS icon
233
Invesco BulletShares 2028 Corporate Bond ETF
BSCS
$3.58B
$3.3M 0.11%
160,273
+18,816
+13% +$387K
GSBD icon
234
Goldman Sachs BDC
GSBD
$1.09B
$3.3M 0.11%
355,305
+4,263
+1% +$41.8K
DFP
235
Flaherty & Crumrine Dynamic Preferred and Income Fund
DFP
$427M
$3.29M 0.11%
158,315
+36,304
+30% +$774K
TRV icon
236
Travelers Companies
TRV
$78.3B
$3.29M 0.11%
11,340
-369
-3% -$104K
KNSA icon
237
Kiniksa Pharmaceuticals
KNSA
$6.07B
$3.27M 0.11%
79,200
-42,619
-35% -$1.71M
SAR icon
238
Saratoga Investment
SAR
$315M
$3.26M 0.11%
141,470
-38,593
-21% -$875K
HII icon
239
Huntington Ingalls Industries
HII
$12.9B
$3.26M 0.11%
9,591
+1,478
+18% +$459K
MAR icon
240
Marriott International
MAR
$91.1B
$3.26M 0.11%
10,512
-3,332
-24% -$952K
MVT
241
DELISTED
BlackRock MuniVest Fund II
MVT
$3.24M 0.11%
299,875
-17,455
-6% -$187K
CDNS icon
242
Cadence Design Systems
CDNS
$90.2B
$3.23M 0.11%
10,346
+947
+10% +$309K
AGD
243
abrdn Global Dynamic Dividend Fund
AGD
$326M
$3.22M 0.11%
276,378
+55,030
+25% +$650K
TMUS icon
244
T-Mobile US
TMUS
$192B
$3.2M 0.11%
15,755
-359
-2% -$76.1K
AEG icon
245
Aegon
AEG
$13.9B
$3.15M 0.11%
408,724
+103,586
+34% +$792K
DTE icon
246
DTE Energy
DTE
$28.6B
$3.07M 0.11%
23,799
+4,032
+20% +$548K
KURA icon
247
Kura Oncology
KURA
$882M
$3.06M 0.11%
294,805
+79,955
+37% +$839K
APH icon
248
Amphenol
APH
$206B
$3.06M 0.11%
22,633
+2,869
+15% +$384K
PPL
249
PPL Corp
PPL
$26.5B
$3.05M 0.11%
87,163
-10,881
-11% -$392K
UTHR icon
250
United Therapeutics
UTHR
$22.1B
$3.05M 0.11%
6,254
-120
-2% -$55.9K
8 9
10
11 12

Similar funds

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BCP
BDT Capital Partners Chicago, Illinois $3.51B AUM 31.02% 1-Year Est. Return
DILIC
Dai-ichi Life Insurance Company Tokyo, Japan $3.49B AUM 27.28% 1-Year Est. Return
TYCC
Texas Yale Capital Corp St. Petersburg, Florida $3.52B AUM 52.63% 1-Year Est. Return
ACM
Aquatic Capital Management Chicago, Illinois $3.48B AUM 24.9% 1-Year Est. Return
MSC
MUFG Securities (Canada) New York $3.48B AUM 45.13% 1-Year Est. Return
DAM
Davis Asset Management Sausalito, California $3.46B AUM 9.77% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return

Hennion & Walsh Asset Management's Q4 2025 Portfolio in Review

As of Q4 2025, Hennion & Walsh Asset Management held 1,008 positions worth $2.9B, up 5% from $2.76B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Hennion & Walsh Asset Management deployed $88.8M of net new capital in Q4 2025, opening 71 new positions and adding to 442 existing holdings. Its largest new stake was Schwab Fundamental International Large Company Index ETF: 53,014 shares worth $2.4M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Rhythm Pharmaceuticals, an estimated $3.59M trimmed.

  • Hennion & Walsh Asset Management's largest Q4 2025 buy was Schwab Fundamental International Large Company Index ETF: 53,014 shares worth $2.4M.
  • Hennion & Walsh Asset Management added most to Invesco Trust Investment Grade Municipals in Q4 2025, an estimated $4.8M increase.
  • Hennion & Walsh Asset Management's biggest Q4 2025 reduction was Rhythm Pharmaceuticals, cutting an estimated $3.59M.
  • Hennion & Walsh Asset Management fully exited Verona Pharma in Q4 2025, selling an estimated $19.8M.
  • Hennion & Walsh Asset Management's ten largest holdings make up 18% of its $2.9B portfolio in Q4 2025.
  • Hennion & Walsh Asset Management opened 71 new positions and closed 82 in Q4 2025.
  • Hennion & Walsh Asset Management's portfolio value rose 5% quarter-over-quarter to $2.9B.

Based on Hennion & Walsh Asset Management's 13F filing for Q4 2025, filed 14 Jan 2026.